Vascepa OverviewEthyl eicosapentaenoic acid (E-EPA, icosapent ethyl) is a medication used to treat hypertriglyceridemia. It is used in combination with changes in diet in adults with hypertriglyceridemia ≥ 150mg/dL. It is made from the omega-3 fatty acid eicosapentaenoic acid (EPA). The US Food and Drug Administration (FDA) granted the approval of it (as Vascepa) in 2012, to Amarin Corporation, and it became the second fish oil-based medication after omega-3 acid e...
Read more Vascepa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ethyl_eicosapentaenoic_acid
Recent Vascepa Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Capsule: 1g, 1gm, 500mg
NDC Database Records for Vascepa: (3 results)Sorted by National Drug Code
- 52937-001 Vascepa 1000 mg Oral Capsule by Amarin Pharma Inc.
- 52937-003 Vascepa 500 mg Oral Capsule by Amarin Pharma Inc.
- 52937-101 Vascepa 1000 mg Oral Capsule by Amarin Pharma Inc.